Virtual Nephrologist
vHCA
An Interactive, Conversational Virtual Healthcare Agent to Educate and Engage Patients With Advanced Chronic Kidney Disease About Transplantation (Part 2: Pilot)
1 other identifier
interventional
148
1 country
2
Brief Summary
To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 26, 2024
CompletedFirst Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 12, 2026
January 1, 2026
1.3 years
February 10, 2025
January 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Median change in Transplant intention Likert scale question from pre- to post-vHCA
Assess the change in intentionally to consider/discuss getting a kidney transplant using 5-point Likert scale survey
1 year
Study Arms (1)
Virtual Nephrologist
EXPERIMENTALInterventions
Quality improvement (QI) pilot of an interactive, conversational virtual healthcare agent to educate and engage patients with advanced CKD about transplantation
Eligibility Criteria
You may qualify if:
- y/o able to provide consent
- Advanced CKD
- English speaking
- Penn Medicine patient
You may not qualify if:
- Vulnerable populations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- University of Floridacollaborator
- Vanderbilt University Medical Centercollaborator
Study Sites (2)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2025
First Posted
February 21, 2025
Study Start
March 26, 2024
Primary Completion
July 14, 2025
Study Completion
December 31, 2025
Last Updated
January 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share